Get started
RocketTickers

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setm

Long
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)  
RocketTickers  
NASDAQ:RYTM   Rhythm Pharmaceuticals, Inc.
Beyond Technical Analysis
0
0
beyondta
RYTM: Rhythm Pharmaceuticals, Inc.
2020-11-27 07:30:00
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.